Loading company…
Tanai Therapeutics is developing an oral obesity treatment.
Tanai Therapeutics is a Belgium-based biotechnology company developing an oral treatment for obesity. Its research targets a pathway involved in energy expenditure, with the aim of promoting fat loss while preserving muscle mass. The company is advancing toward in-vivo proof-of-concept based on research at the VIB-UGent Center for Inflammation Research. In September 2024, it raised seed funding from Novo Nordisk A/S and BioGeneration Ventures, with participation from V-Bio Ventures, Qbic, and VIB.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in